 prognost valu lymphocyt surfac marker acut myeloid leukemia express cell surfac myeloid lymphoid leukemia bone marrow-deriv blast cell patient acut myeloid leukemia aml cancer leukemia group calgb chemotherapi protocol case express t-cell marker sheep erythrocyt bind receptor lymphocyt posit addit patient b-lymphocyt marker posit overal patient posit central review french-american-british fab morpholog case fab frequent time frequent case lymphocyt antigen-posit case cell avail studi Ig t-cell antigen receptor tcr gene rearrang germlin Ig heavi chain gene tcr beta Ig chain gene presenc messeng rna surfac antigen-posit case cell surfac data lymphocyt antigen-posit case karyotyp aml case abnorm clone invers patient lymphocyt marker incid karyotyp abnorm patient lymphocyt antigen-neg aml outcom therapi lymphocyt antigen-posit case case case complet remiss rate time failur year overal surviv year antigen-posit case superior surviv year signific differ equal group age leukocyt count diagnosi incid extramedullari diseas fab classif abstract truncat AT word